Investing.com Earnings
Pennant group chief clinical officer sells $53,699 in stock
Pennant Group's Chief Clinical Officer, Jason Paul Steik, recently sold 1,394 shares of company stock for a total of $53,699. This transaction follows strong stock performance, with PNTG shares up 55.66% over the past year and 39.68% year-to-date, although the stock appears overvalued according to InvestingPro analysis. The company also recently reported strong Q2 2026 financial results, surpassing …